49 236 в молекулата на обратната транскриптаза, не показва кръстосана резистентност с ефавиренц.
Viral isolates recovered from PBMCs of patients enrolled in efavirenz clinical studies who showed evidence of treatment failure (viral load rebound) were assessed for susceptibility to NNRTIs.